241 related articles for article (PubMed ID: 3378211)
1. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
[TBL] [Abstract][Full Text] [Related]
2. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles.
Montcourrier P; Mangeat PH; Salazar G; Morisset M; Sahuquet A; Rochefort H
Cancer Res; 1990 Sep; 50(18):6045-54. PubMed ID: 2393869
[TBL] [Abstract][Full Text] [Related]
4. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells.
Freiss G; Vignon F; Rochefort H
Cancer Res; 1988 Jul; 48(13):3709-15. PubMed ID: 2454153
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures.
Erdmann S; Ricken A; Hummitzsch K; Merkwitz C; Schliebe N; Gaunitz F; Strotmann R; Spanel-Borowski K
Eur J Cell Biol; 2008 May; 87(5):311-23. PubMed ID: 18387691
[TBL] [Abstract][Full Text] [Related]
7. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.
Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H
Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531
[TBL] [Abstract][Full Text] [Related]
8. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.
Maynadier M; Farnoud R; Lamy PJ; Laurent-Matha V; Garcia M; Rochefort H
Int J Oncol; 2013 Nov; 43(5):1683-90. PubMed ID: 24026424
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
[TBL] [Abstract][Full Text] [Related]
11. The role of cathepsin D in the invasiveness of human breast cancer cells.
Johnson MD; Torri JA; Lippman ME; Dickson RB
Cancer Res; 1993 Feb; 53(4):873-7. PubMed ID: 8428368
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical significance of cathepsin D in breast cancer.
Rochefort H
Semin Cancer Biol; 1990 Apr; 1(2):153-60. PubMed ID: 2103491
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.
Liaudet-Coopman E; Beaujouin M; Derocq D; Garcia M; Glondu-Lassis M; Laurent-Matha V; Prébois C; Rochefort H; Vignon F
Cancer Lett; 2006 Jun; 237(2):167-79. PubMed ID: 16046058
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?
Rochefort H; Capony F; Garcia M; Cavaillès V; Freiss G; Chambon M; Morisset M; Vignon F
J Cell Biochem; 1987 Sep; 35(1):17-29. PubMed ID: 3312245
[TBL] [Abstract][Full Text] [Related]
15. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
[TBL] [Abstract][Full Text] [Related]
16. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
Nakajima M; Welch DR; Belloni PN; Nicolson GL
Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
[TBL] [Abstract][Full Text] [Related]
18. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
Webber MM; Waghray A
Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
[TBL] [Abstract][Full Text] [Related]
20. Role of thrombin receptor in breast cancer invasiveness.
Henrikson KP; Salazar SL; Fenton JW; Pentecost BT
Br J Cancer; 1999 Feb; 79(3-4):401-6. PubMed ID: 10027305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
